compounding glp-1 news FDA proposes a new crackdown Out of Shortage, Into Controversy:

Compare Mounjaro vs Ozempic to understand their differences, benefits, and effectiveness in medical weight management.

People on GLP-1s lose weight

SCFAs mediate systemic antioxidant responses via gut-organ axis communication, while EVs ameliorate intestinal barrier dysfunction through MAPK signaling pathway modulation

With the successive launch of Glucagon-like peptide-1 (GLP-1) class drugs that allow weight loss with a once-daily pill instead of an injection, the barrier to obesity treatment is lowering

Thus, the SELECT trial exceeded expectations (many commentators predicted the topline reduction to be likely sub-20%), but also underlined the need for further outcomes trials to clarify other potential benefits, as well as, for competitors, meeting or exceeding the performance of Wegovy

Consult your doctor in case you are taking any other medication